Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated:  6/27/2016
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated: 6/27/2016
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated:  6/27/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated: 6/27/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated:  6/27/2016
Avera Cancer Institute
mi
from
Sioux Falls, SD
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated: 6/27/2016
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated:  6/27/2016
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated: 6/27/2016
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated:  6/27/2016
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated: 6/27/2016
Sioux Valley Hospital at University of South Dakota Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated:  6/27/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Status: Enrolling
Updated: 6/27/2016
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Click here to add this to my saved trials
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Smoking Relapse Prevention Among Postpartum Women
Status: Enrolling
Updated:  6/27/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Smoking Relapse Prevention Among Postpartum Women
Status: Enrolling
Updated: 6/27/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/28/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/28/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Gemcitabine and CT-011 for Resected Pancreatic Cancer
A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and Anti-PD1 Monoclonal Antibody (CT-011) in the Treatment of Resected Pancreatic Cancer
Status: Enrolling
Updated:  6/28/2016
Augusta University
mi
from
Augusta, GA
Gemcitabine and CT-011 for Resected Pancreatic Cancer
A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and Anti-PD1 Monoclonal Antibody (CT-011) in the Treatment of Resected Pancreatic Cancer
Status: Enrolling
Updated: 6/28/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated:  6/28/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated: 6/28/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated:  6/28/2016
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Nashville, TN
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated: 6/28/2016
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Nashville, TN
Click here to add this to my saved trials
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
The Relationship of Serum 25-Hydroxyvitamin D to Overall Survival in Advanced Pancreatic Cancer
Status: Enrolling
Updated:  6/28/2016
Charles R. Wood Cancer Center at Glens Falls Hospital
mi
from
Glens Falls, NY
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
The Relationship of Serum 25-Hydroxyvitamin D to Overall Survival in Advanced Pancreatic Cancer
Status: Enrolling
Updated: 6/28/2016
Charles R. Wood Cancer Center at Glens Falls Hospital
mi
from
Glens Falls, NY
Click here to add this to my saved trials
POWER-remote Weight Loss Program in Early Stage Breast Cancer
A Randomized Study Evaluating the Effect of a Remote-Based Weight Loss Program (POWER-remote) on Biomarkers in Women With Early Stage Breast Cancer
Status: Enrolling
Updated:  6/28/2016
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
POWER-remote Weight Loss Program in Early Stage Breast Cancer
A Randomized Study Evaluating the Effect of a Remote-Based Weight Loss Program (POWER-remote) on Biomarkers in Women With Early Stage Breast Cancer
Status: Enrolling
Updated: 6/28/2016
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated:  6/28/2016
Clinical Research Facility
mi
from
Denver, CO
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated: 6/28/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated:  6/28/2016
Clinical Research Facility
mi
from
Greenville, SC
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated: 6/28/2016
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated:  6/28/2016
Clinical Research Facility
mi
from
Nashville, TN
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated: 6/28/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated:  6/28/2016
Clinical Research Facility
mi
from
Houston, TX
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated: 6/28/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated:  6/28/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated: 6/28/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated:  6/28/2016
Research Site
mi
from
Cambridge,
Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
A Phase I, Open-Label, Multicentre, Dose-Escalation Study to Investigate the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Status: Enrolling
Updated: 6/28/2016
Research Site
mi
from
Cambridge,
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
University of Minnesota Medical School
mi
from
Minneapolis, MN
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
University of Minnesota Medical School
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated:  6/28/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis
Status: Enrolling
Updated: 6/28/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
Status: Enrolling
Updated:  6/28/2016
Methodist Hospital
mi
from
Indianapolis, IN
Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
Status: Enrolling
Updated: 6/28/2016
Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
Kaiser Permanente Medical Office -Vandever Medical Office
mi
from
San Diego, CA
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
Kaiser Permanente Medical Office -Vandever Medical Office
mi
from
San Diego, CA
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
Tunnell Cancer Center at Beebe Medical Center
mi
from
Lewes, DE
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
Tunnell Cancer Center at Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
Union Hospital Cancer Program at Union Hospital
mi
from
Elkton MD, MD
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
Union Hospital Cancer Program at Union Hospital
mi
from
Elkton MD, MD
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
Cancer Institute of New Jersey at Cooper - Voorhees
mi
from
Voorhees, NJ
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
Cancer Institute of New Jersey at Cooper - Voorhees
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
Kinston Medical Specialists
mi
from
Kinston, NC
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated:  6/28/2016
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin
Status: Enrolling
Updated: 6/28/2016
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic
A Phase I Study of the PI3-Kinase Inhibitor BKM120 in Combination With Docetaxel in Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  6/29/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic
A Phase I Study of the PI3-Kinase Inhibitor BKM120 in Combination With Docetaxel in Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 6/29/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  6/29/2016
Peggy and Charles Stephenson Cancer Center
mi
from
Oklahoma City, OK
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 6/29/2016
Peggy and Charles Stephenson Cancer Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  6/29/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 6/29/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  6/29/2016
Florida Cancer Specialists
mi
from
Sarasota, FL
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
A Phase I Study to Assess the Food Effect on the Pharmacokinetics of Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer and Men and Women With Progressive Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 6/29/2016
Florida Cancer Specialists
mi
from
Sarasota, FL
Click here to add this to my saved trials
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated:  6/29/2016
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated: 6/29/2016
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated:  6/29/2016
Decatur Memorial Hospital
mi
from
Decatur, IL
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated: 6/29/2016
Decatur Memorial Hospital
mi
from
Decatur, IL
Click here to add this to my saved trials
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated:  6/29/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated: 6/29/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated:  6/29/2016
Illinois Cancer Care - Peoria
mi
from
Peoria, IL
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
DCE-MRI as Pazopanib Biomarker in Metastatic Renal Cancer
Status: Enrolling
Updated: 6/29/2016
Illinois Cancer Care - Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Phase II Study of Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Status: Enrolling
Updated:  6/29/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Phase II Study of Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors
Status: Enrolling
Updated: 6/29/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
A Phase II Study of Carboplatin, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Avastin as the First Line Therapy in Metastatic Breast Cancer.
Status: Enrolling
Updated:  6/30/2016
Good Samaritan Cancer Care Center at Advocate Good Samaritan Hospital
mi
from
Downers Grove, IL
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
A Phase II Study of Carboplatin, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Avastin as the First Line Therapy in Metastatic Breast Cancer.
Status: Enrolling
Updated: 6/30/2016
Good Samaritan Cancer Care Center at Advocate Good Samaritan Hospital
mi
from
Downers Grove, IL
Click here to add this to my saved trials